These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. European Medicines Agency guideline on bioanalytical method validation: what more is there to say? Smith G Bioanalysis; 2012 May; 4(8):865-8. PubMed ID: 22533559 [No Abstract] [Full Text] [Related]
4. Process analytical technology and ASTM Committee E55. Watts DC; Afnan AM; Hussain AS Stand News; 2004 May; 32(5):25-7. PubMed ID: 15146856 [No Abstract] [Full Text] [Related]
5. Development of official methods by the Association of Official Analytical Chemists. Ensminger LG Health Lab Sci; 1966 Jul; 3(3):143-50. PubMed ID: 5942489 [No Abstract] [Full Text] [Related]
6. New standards for test laboratories. Hecht A FDA Consum; 1977 Mar; 11(2):22-5. PubMed ID: 10304988 [No Abstract] [Full Text] [Related]
7. A timely re-examination of drug polymorphism in pharmaceutical development and regulation. Grant DJ; Byrn SR Adv Drug Deliv Rev; 2004 Feb; 56(3):237-9. PubMed ID: 14962580 [No Abstract] [Full Text] [Related]
8. A short course on the Food and Drug Administration: what you should know. Fourcroy JL J Androl; 2002; 23(6):754-6. PubMed ID: 12399516 [No Abstract] [Full Text] [Related]
9. Special labeling requirements for genetically engineered food: how sound are the analytical frameworks used by FDA and food producers? Winn LB Food Drug Law J; 1999; 54(4):667-88. PubMed ID: 11824460 [No Abstract] [Full Text] [Related]
10. Regulatory philosophy for comparability protocols. Moos M Dev Biol (Basel); 2002; 109():53-6. PubMed ID: 12434913 [TBL] [Abstract][Full Text] [Related]
11. FDA and clinical labs: beginning a dialogue. Javitt G MLO Med Lab Obs; 2007 May; 39(5):52, 50. PubMed ID: 18396740 [No Abstract] [Full Text] [Related]
12. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
13. Massachusetts city attempts to import drugs form Canada. Caroll J Manag Care; 2003 Oct; 12(10):16-7. PubMed ID: 14598537 [No Abstract] [Full Text] [Related]
14. Transgenic salmon still out in the cold in United States. Hoag H Nature; 2003 Jan; 421(6921):304. PubMed ID: 12540865 [No Abstract] [Full Text] [Related]
15. PAT Program report: background and current status. Grunder FI; AIHA J (Fairfax, Va); 2002; 63(6):797-8. PubMed ID: 12570089 [No Abstract] [Full Text] [Related]
16. Abbott Laboratories Consent Decree and individual responsibility under the Federal Food, Drug, and Cosmetic Act. Blumberg EM Food Drug Law J; 2000; 55(1):145-9. PubMed ID: 12322721 [No Abstract] [Full Text] [Related]
17. Secondhand woes. FDA rethinking the rules on refurbished devices. What could that mean for you? Gwynne P Health Facil Manage; 1998 Nov; 11(11):46, 48, 50-2. PubMed ID: 10345426 [No Abstract] [Full Text] [Related]
18. How the GM industry writes its own rules. Bereano PL Nature; 2000 Jun; 405(6788):733. PubMed ID: 10866176 [No Abstract] [Full Text] [Related]
19. Pharmacogenomics: an in-house advantage? Borchardt PE Drug Discov Today; 2006 Jan; 11(1-2):1-3. PubMed ID: 16478684 [No Abstract] [Full Text] [Related]
20. The impact of Abbott's consent decree on clinical laboratories. Assarian GS MLO Med Lab Obs; 2000 Sep; 32(9):56-8. PubMed ID: 11184639 [No Abstract] [Full Text] [Related] [Next] [New Search]